Canaccord Genuity Starts Intersect ENT (XENT) at Buy

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/13/2026

Price: $28.24 --0%

Rating Summary:
4 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0

Canaccord Genuity initiated coverage on Intersect ENT (NASDAQ: XENT) with a Buy rating and a price target of $27.00.

For an analyst ratings summary and ratings history on Intersect ENT click here. For more ratings news on Intersect ENT click here.

Shares of Intersect ENT closed at $23.71 yesterday.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!